Member Info for Matml74

It certainly will be. Lets hope the Americans pile in once Activ-2 is announced.

MD, yep but it is aim after all.

These are all negotiated trades been worked through the system last few weeks. The price will move once these orders are finished.

You would think a TR1 later today a possibility based on the large trades. Been plenty of them all week.

Two more just went through Sheep. We are in an order filling range it seems.

Nice work Oxford. The great professor has been talking prophylaxis since November so there must be a chance to be included in this one as well. We will know in the next few weeks.

I was just joking. The difference between us and the great professor is that this has been his life for 15 years. He really does know. He knows it’s safe. Years of clinical data on that. He knows it acts as an antiviral, years of lab and clinical trial data to show that.

No sleepless night here either Doc. Very happy with the interview today. The professor knows!

I might go through them later if I have time. The largest trade below looks like a buy. Bid was 165.5 and Ask 166.9

13-Jan-21 12:05:47 166.573 151,860 Sell* 252.96k

The COPD trial is not completed yet. There are still 10 patients to recruit. It is ON HOLD. The data set is an interim to support the COVID work. This board has been over this topic countless times.

There is none Phil. It has been clearly RNS's why it was stopped as outlined below. It had nothing to do with the data set. Ignore the idiots.

Why are the recruiting manufacturing staff? All of the manufacturing is already contracted out. Initially this is going to be run by SNG.

BFS production will be essential and the manufacturers they are working with are already on the case with this. Also preferred method of FDA!!!!

" Acknowledged by the FDA as an advanced aseptic process for the packaging of sterile pharmaceutical liquids, blow-fill-seal technology is gaining increasing acceptance by providing a high assurance of product sterility, eliminating the need for human intervention, improving flexibility in container design and increasing process uptime."

Sphunken, You are the last person that I would think would be deramping this share. Ignore and move on.

Agree Tommy. Utmost respect with what Richard has managed to achieve this year. Can't be too many pharma bosses that ever managed to get a P2 and P3 trial done within 12 months.

Kansas is new favourite US state!

It’s part of US’s operation warpspeed which brings massive support from US government for upscaling production and hence large orders from the US gov. Also EUA likely to done quickly by FDA if there is an indication that SNG001 treatment is working.

Activ-2 has about 90 trial sites so patient recruitment will be very quick.

Goodluck Sterland. Am sure you will be well looked after.

Booky, You really need to check her credentials. She is a self promoter being portrayed by the BBC as an expert. Her CV shows she clearly is not a respiratory clinician! It was poor journalism and the BBC should be questioned on this.

She's a botox doctor FFS. I have made my complaint to the BBC. Only 2 weeks to wait to get a response!

It's in the RNS.

"After reporting the results for the primary and key secondary endpoints of the study, enrolled patients will continue to be assessed for long-COVID-19 symptoms."